Client Type: AC Graduates
Mespere Lifesciences Inc. is a start-up focused on developing the next generation of medical devices. Mespere’s proprietary technology provides breakthrough real time non-invasive cardiac visualization. An estimated 80 million Americans have one or more types of cardiovascular disease (CVD). Nearly 2,400 Americans die of CVD each day, an average of one death every 37 seconds. Nearly 17 million people worldwide die every year from cardiovascular disease. Mespere is developing a non-invasive product pipeline based upon near infrared spectroscopy to non-invasively measure the central venous pressure within central venous blood vessels. The CVP monitor provides comprehensive information to help assess and monitor patients, reducing costs while maintaining patient care.